Financials

News Ideas Discussions Technicals Forecast Seasonals Options

Cost of goods sold of Recursion Pharmaceuticals, Inc.

Annual data

2020

2021

2022

2023

2024

TTM

‪‪−64.00 M‬‬

‪‪−48.00 M‬‬

‪‪−32.00 M‬‬

‪‪−16.00 M‬‬

‪0.00‬

Period

Value

Change

Change %

TTM

‪‪−63.53 M‬‬

‪‪−100.00 K‬‬

‪−0.16‬%

2024

‪‪−63.43 M‬‬

‪‪−12.35 M‬‬

‪−24.16‬%

2023

‪‪−51.09 M‬‬

‪‪−2.43 M‬‬

‪−5.00‬%

2022

‪‪−48.65 M‬‬

‪‪−39.55 M‬‬

‪−434.42‬%

2021

‪‪−9.10 M‬‬

—

—

2020

—

—

—

Quarterly data

Q2 '20

Q3 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪‪−24.00 M‬‬

‪‪−18.00 M‬‬

‪‪−12.00 M‬‬

‪‪−6.00 M‬‬

‪0.00‬

Period

Value

Change

Change %

Q4 '24

‪‪−19.69 M‬‬

‪‪−3.51 M‬‬

‪−21.69‬%

Q3 '24

‪‪−16.18 M‬‬

‪‪−3.08 M‬‬

‪−23.51‬%

Q2 '24

‪‪−13.10 M‬‬

+‪‪1.47 M‬‬

+‪10.07‬%

Q1 '24

‪‪−14.57 M‬‬

+‪‪8.91 M‬‬

+‪37.97‬%

Q4 '23

‪‪−23.48 M‬‬

‪‪−9.20 M‬‬

‪−64.47‬%

Q3 '23

‪‪−14.28 M‬‬

‪‪−3.29 M‬‬

‪−30.00‬%

Q2 '23

‪‪−10.98 M‬‬

+‪‪1.62 M‬‬

+‪12.84‬%

Q1 '23

‪‪−12.60 M‬‬

‪‪−1.61 M‬‬

‪−14.64‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q3 '20

Q2 '20